Your browser doesn't support javascript.
loading
Bioluminescent Study of the Distribution of High-Molecular-Weight Protein Fraction of Cellex Daily Preparation in the Brain after Intranasal Administation.
Baklaushev, V P; Yusubalieva, G M; Burenkov, M S; Mel'nikov, P A; Bozhko, E A; Mentyukov, G A; Lavrent'eva, L S; Sokolov, M A; Chekhonin, V P.
Affiliation
  • Baklaushev VP; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical-Biological Agency, Moscow, Russia. serpoff@gmail.com.
  • Yusubalieva GM; V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.
  • Burenkov MS; Farm-Sintez Company, Moscow, Russia.
  • Mel'nikov PA; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical-Biological Agency, Moscow, Russia.
  • Bozhko EA; V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.
  • Mentyukov GA; Farm-Sintez Company, Moscow, Russia.
  • Lavrent'eva LS; Farm-Sintez Company, Moscow, Russia.
  • Sokolov MA; Farm-Sintez Company, Moscow, Russia.
  • Chekhonin VP; Farm-Sintez Company, Moscow, Russia.
Bull Exp Biol Med ; 164(2): 285-292, 2017 Dec.
Article in En | MEDLINE | ID: mdl-29177876
ABSTRACT
Permeability of the blood-brain barrier for protein fractions 50-100 kDa (PF50-100) of Cellex Daily preparation labeled with fluorescent tracer FITC and non-conjugated FITC were compared after intranasal administration of the preparations to healthy rats. Fluorimetrical analysis of the serum and cerebrospinal fluid samples showed that Cellex Daily PF50-100-FITC administered intranasally penetrated into the blood and cerebrospinal fluid with maximum accumulation in 2 h after administration and persists in the circulation for 24 h probably due to binding with plasma proteins. The differences in the kinetic profile of PF50-100-FITC and free FITC indirectly suggest that the major part of the preparation is not degraded within 24 h and FITC is probably not cleaved from the protein components of the preparation. In vivo fluorescence analysis showed significant fluorescent signal in the olfactory bulbs in 6 h after intranasal administration; hence, the preparation administered via this route can bypass the blood-brain barrier. Scanning laser confocal microscopy of rat brain sections confirmed penetration of the high-molecular weight protein fraction PF50-100-FITC into CNS structures. The most pronounced accumulation of the labeled drug was observed in the olfactory bulb in 6 and 12 h after administration. In contrast to free FITC administered in the control group, significant accumulation of PF50-100-FITC in the olfactory cortex and frontal cortex neurons with functionally active nuclei was observed in 6, 12 and 24 h after intranasal administration.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Olfactory Bulb / Peptides / Blood-Brain Barrier / Neuroprotective Agents / Frontal Lobe / Nerve Tissue Proteins Limits: Animals Language: En Journal: Bull Exp Biol Med Year: 2017 Document type: Article Affiliation country: RUSSIA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Olfactory Bulb / Peptides / Blood-Brain Barrier / Neuroprotective Agents / Frontal Lobe / Nerve Tissue Proteins Limits: Animals Language: En Journal: Bull Exp Biol Med Year: 2017 Document type: Article Affiliation country: RUSSIA